DICE THERAPEUTICS
DICE Therapeutics is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DICE is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to their systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas... . The Company’s DELSCAPE platform is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. DICE’s lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. DICE is also developing oral therapeutic candidates targeting α4ß7 integrin and αVß1/αVß6 integrin for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis, respectively.
DICE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Medical Device
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.dicetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(650) 566-1402
Email Addresses:
[email protected]
Total Funding:
187.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt IPv6 AJAX Libraries API COVID-19 JQuery CDN CloudFront New Relic
Similar Organizations
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
BlueLight Therapeutics
BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.
CODA Biotherapeutics
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eventide
Eventide investment in Series C - Dice Therapeutics
Logos Capital
Logos Capital investment in Series C - Dice Therapeutics
Soleus Capital
Soleus Capital investment in Series C - Dice Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Dice Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series C - Dice Therapeutics
Asymmetry Capital Management
Asymmetry Capital Management investment in Series C - Dice Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series C - Dice Therapeutics
Northpond Ventures
Northpond Ventures investment in Series C - Dice Therapeutics
Sands Capital Ventures
Sands Capital Ventures investment in Series C - Dice Therapeutics
Deep Track Capital
Deep Track Capital investment in Series C - Dice Therapeutics
Official Site Inspections
http://www.dicetherapeutics.com Semrush global rank: 722.62 K Semrush visits lastest month: 56.89 K
- Host name: 172.64.151.74
- IP address: 172.64.151.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Dice Therapeutics"
About - DICE THERAPEUTICS
We are a clinical-stage biopharmaceutical company combining innovative chemistry with well-validated biology to make medicines more accessible for people living with chronic autoimmune and inflammatory diseases.See details»
Dice Therapeutics - Crunchbase Company Profile
DICE Therapeutics is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to …See details»
DICE Therapeutics Expands Management Team and Board of …
Mar 28, 2022 Rhia Ventures, a social venture investment organization focused on reproductive health. She was also the chief operating officer of the Tara Health Foundation and had an …See details»
DICE Therapeutics 2025 Company Profile: Valuation, …
DICE Therapeutics General Information Description. DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to …See details»
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and ...
Organization Website: dicetherapeutics.com : Contact Email [email protected] DICE Therapeutics, I... industries Biotech: Headquarters Location: 279 E. Grand Avenue, South San Francisco, …See details»
DICE Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DICE Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
DICE Therapeutics Company Profile | Management and Employees …
Company Name. DICE Therapeutics. Main Industry. Research & Development, Business Services. Website. www.dicetherapeutics.comSee details»
DICE Therapeutics - VentureRadar
Website: https://www.dicetherapeutics.com. Designs and develops innovative immunology therapies, focusing on creating convenient oral medicines with biologic-like efficacy for …See details»
DICE Therapeutics - LifeScienceHistory.com
DICE Therapeutics www.dicetherapeutics.com. 400 East Jamie Court, Suite 300. Company Info Year Established 2013 Ticker LLY Exchange NYSESee details»
DICE Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.dicetherapeutics.com. Public Company | Subsidiary Company | 2013 | California, United States | 50-100 | NASDAQ: DICE | www.dicetherapeutics.com. Last update 23 Jan 2025. …See details»
DICE Therapeutics - Overview, News & Similar companies
DICE Therapeutics contact info: Phone number: (650) 566-1402 Website: www.dicetherapeutics.com What does DICE Therapeutics do? DICE Therapeutics is a …See details»
Contacts, Employees, Board Members, Advisors & Alumni
Organization. Dice Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
DICE Therapeutics - workinbiotech.com
Founded: 2013 Location: South SF, CA Employee range: 50 - 200 Clinical stage: Clin1 Therapy area: Psoriasis, immune-mediated conditions Drug types: IMM, DRM, GI, ONC Lead product: …See details»
DICE Therapeutics Inc Company Profile - Overview - GlobalData
Website www.dicetherapeutics.com Telephone 1 650 5661402. Industry Pharmaceuticals and Healthcare . Gain access to our premium ...See details»
DICE Therapeutics Company Profile - Office Locations ... - Craft
Aug 18, 2023 DICE Therapeutics has 1 employees at their 1 location and $1.13 m in annual revenue in FY 2021. See insights on DICE Therapeutics including office locations, …See details»
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and ...
Jun 11, 2023 dicetherapeutics.com. SIC Code 8733 - Noncommercial Research Organizations. NAICS Code 541714 - Research and Development in Biotechnology (except …See details»
Nextsource | Company Profile | Dice Therapeutics
Explore the company profile of Dice Therapeutics (dicetherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
DICE Therapeutics Inc. - Cruelty Free Investing
Dice Therapeutics, Inc., formerly Dice Molecules Holdings LLC, is a biopharmaceutical company. The Company leverages its technology platform to build a pipeline of oral therapeutic …See details»
Press Release - DICE THERAPEUTICS
400 East Jamie Court Suite 300 South San Francisco CA 94080See details»
DNA organization offers clues for advancing stem cell therapy
2 days ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll …See details»